ATTR-CM: A life-threatening disease that can go undetected1
Living with ATTR-CM
Early detection of ATTR-CM is essential1
Uncover the clues of ATTR-CM
![Carousel Mobile Image](/sites/default/files/2020-10/mobile-carousel-image_3_0_18.jpg)
Transthyretin amyloid cardiomyopathy (ATTR-CM):
A LIFE-THREATENING DISEASE
THAT CAN GO UNDETECTED1
WHAT IS ATTR-CM?![Carousel Mobile Image](/sites/default/files/2020-10/mobile-carousel-image_2_0_0_18.jpg)
Transthyretin amyloid cardiomyopathy (ATTR-CM):
WHAT IS IT LIKE TO
LIVE WITH ATTR-CM?
HEAR FROM PATIENTS![Carousel Image](/sites/default/files/2020-11/carousel_image_4_0_0_2_0_0_5_18.jpg)
![Carousel Mobile Image](/sites/default/files/2020-10/mobile-carousel-image_1_0_0_18.jpg)
Transthyretin amyloid cardiomyopathy (ATTR-CM):
EARLY DETECTION OF ATTR-CM IS KEY
TO IMPROVED CARE AND OUTCOMES1
DETECTWhy every heart mATTRs
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially life-threatening condition that affects the heart and is associated with heart failure. Early detection and prompt management of ATTR-CM is essential to optimise the prognosis of people with this condition.1
Every Heart mATTRs exists to provide healthcare professionals and people who may be living with ATTR-CM with the information and resources to help identify this potentially fatal condition that has been living in the shadows of heart failure.
- Witteles RM et al. JACC Heart Fail 2019;7(8):709–16.